Analgesic nephropathy - Continuous phenacetin consumption Factor
Last reviewed for CCPS 20 August 2008.
Investigative Documents
Medical Report - Phenacetin - Analgesic Nephropathy [MR9028] Preliminary questions [39951] 39962 — the veteran has established the causal connection between continuous phenacetic consumption and VEA service for the clinical onset of analgesic nephropathy. 39963 — the veteran has established the causal connection between continuous phenacetic consumption and operational service for the clinical onset of analgesic nephropathy. or 39964 — the veteran has established the causal connection between continuous phenacetic consumption and eligible service for the clinical onset of analgesic nephropathy. Clinical onset and operational service [39963] 39132 — the identified illness or injury, which made a material contribution to the veteran's consumption of phenacetin in phenacetin-containing analgesics, is causally related to operational service. [4] [5] Clinical onset and eligible service [39964]
39133 — the identified illness or injury, which made a material contribution to the veteran's consumption of phenacetin in phenacetin-containing analgesics, is causally related to eligible service. [9] [5]
Links
[1] https://clik.dva.gov.au/ccpsmedical-193
[2] clikpopup://CCPS/reject39957No
[3] clikpopup://CCPS/reject39958No
[4] clikpopup://CCPS/reject39959No
[5] clikpopup://CCPS/reject39132,39133No
[6] clikpopup://CCPS/Illness contributed to consumption of at least 2g per day of phenacetin for at least 1 year
[7] clikpopup://CCPS/reject39960No
[8] clikpopup://CCPS/reject39961No
[9] clikpopup://CCPS/reject39133No